Standard “off-the-shelf” multibranched thoracoabdominal endograft in urgent and elective patients with single and staged procedures in a multicenter experience

Silingardi, Roberto; Gennai, Stefano; Leone, Nicola; Gargiulo, Mauro; Faggioli, Gianluca; Cao, Piergiorgio; Verzini, Fabio; Ippoliti, Arnaldo; Tusini, Nicola; Ricci, Carmelo; Antonello, Michele; Chiesa, Roberto; Marone, Enrico Maria; Mangialardi, Nicola; Speziale, Francesco; Veraldi, Gian Franco; Bonardelli, Stefano; Marcheselli, Luigi; Lonardi, Roberto; Saitta, Giuseppe; Lauricella, Antonio; Ferrer, Ciro; Simonte, Gioele; Pratesi, Giovanni; Fontana, Antonio; Lucatelli, Pierleone; Dall’Antonia, Alberto; Bertoglio, Luca; Ronchey, Silvia; Mansour, Wassim; Mezzetto, Luca; Cuomo, Raffaele

doi:10.1016/j.jvs.2017.08.068

Cited by 59 publications

(42 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…62 The outcomes of FEVAR and b-EVAR have been reported from various institutions. [62][63][64][65][66][67][68][69][70][71][72] Technical success was achieved in 90 to 97% of elective cases. The 30-day mortality was 0 to 9%, the occurrence rate of SCI was 4 to 12%, and the visceral vessel patency rate was 90 to 100%.…”

Section: Thoracoabdominal Aortic Aneurysmmentioning

confidence: 96%

Endovascular Treatment of Various Aortic Pathologies: Review of the Latest Data and Technologies

2018

View full text Add to dashboard Cite

The technologies and innovations applicable to endovascular treatment for complex aortic pathologies have progressed rapidly over the last two decades. Although the initial outcomes of an endovascular aortic repair have been excellent, as long-term data became available, complications including endoleaks, endograft migration, and endograft infection have become apparent and are of concern. Previously, the indication for endovascular therapy was restricted to descending thoracic aortic aneurysms and abdominal aortic aneurysms. However, its indication has expanded along with the improvement of techniques and devices, and currently, it has become possible to treat pararenal aortic aneurysms and Crawford type 4 thoracoabdominal aortic aneurysm (TAAA) using the off-the-shelf devices. Additionally, custom-made devices allow for the treatment of arch or more extensive TAAAs. Endovascular treatment is applied not only to aneurysms but also to acute/chronic dissections. However, long-term outcomes are still unclear. This article provides an overview of available devices and the results of endovascular treatment for various aortic pathologies.

show abstract

Section: Thoracoabdominal Aortic Aneurysmmentioning

confidence: 96%

Endovascular Treatment of Various Aortic Pathologies: Review of the Latest Data and Technologies

2018

View full text Add to dashboard Cite

show abstract

“…Stent grafts for F/BEVAR are custom made and therefore, take time to be prepared, whereas PMSG 9,10) and snorkel techniques 11) can be performed using off-the-shelf-devices and are suitable for emergency cases. Recent studies have reported using off-the-shelf devices, such as multibranched endografts or t-Branch (Cook Medical, Bloomington, IN, USA) 12–14) and multilayer flow modulator stents (MFMS: Cardiatis, Isnes, Belgium) 15) as well. A hybrid surgery bypasses the abdominal branch and performs thoracic endovascular aortic repair (TEVAR).…”

Section: Endovascular Treatment Using Stent Graft For Thoracoabdominamentioning

confidence: 99%

Midterm Results of Endovascular Treatment for the Patients with Thoracoabdominal Aortic Aneurysms

Kanaoka

Ohki

2019

Annals of Vascular Diseases

View full text Add to dashboard Cite

Treatment of thoracoabdominal aortic aneurysm (TAAA) remains a challenging pathology. Technologies and innovations of endovascular treatment, in particular the evolution of fenestrated and branched stent graft for complex aortic pathologies such as TAAA have provided excellent short-term results. However, the mid-term and long-term results of endovascular treatment for TAAA including endoleaks and branch patency are still unclear. This article provides an overview of available devices and results of endovascular treatment for TAAAs. (This is a translation of Jpn J Vasc Surg 2019; 28: 67–74.)

show abstract

“…In cases of visceral artery involvement, with more than two vessels, we always check for feasibility of an offthe-shelf complex solution. t-Branch from Cook is indicated for aneurysms with important proximal extension, and one of the most frequent reasons for unsuitability is generally the diameter of the aorta which should at least be 30 mm at the visceral segment [11]. In cases of unsuitability, we then look for a custom solution.…”

Section: Fevar and Bevarmentioning

confidence: 99%

Current Trends of Treatment Options for Complex Aortic Pathology with Visceral Artery Involvement in a Large Single-Center Experience

Mangialardi

Orrico

Ronchey

et al. 2019

Visceral Vessels and Aortic Repair

Self Cite

View full text Add to dashboard Cite

Standard “off-the-shelf” multibranched thoracoabdominal endograft in urgent and elective patients with single and staged procedures in a multicenter experience

Abstract: The first off-the-shelf multibranched endograft seems safe in both urgent/emergent and elective settings. The staged surgical approach appears to positively influence overall survival. This unique device and its operators will usher in a new treatment paradigm for TAAA repair.

Cited by 59 publications

References 37 publications

Endovascular Treatment of Various Aortic Pathologies: Review of the Latest Data and Technologies

Endovascular Treatment of Various Aortic Pathologies: Review of the Latest Data and Technologies

Midterm Results of Endovascular Treatment for the Patients with Thoracoabdominal Aortic Aneurysms

Current Trends of Treatment Options for Complex Aortic Pathology with Visceral Artery Involvement in a Large Single-Center Experience

Contact Info

Product

Resources

About